Are the new 2023 ACR/EULAR classification criteria suitable for advancing the knowledge of obstetric antiphospholipid syndrome?

被引：0

作者：

Martinez-Taboada, Victor M. ^{[1
,5
]}

Gomez, Ana Micieces ^{[1
]}

Merino, Ana ^{[2
]}

Lopez-Hoyos, Marcos ^{[3
,6
]}

del Barrio-Longarela, Sara ^{[2
]}

Comins-Boo, Alejandra ^{[3
]}

Galvez, Rafael ^{[1
]}

Hernandez, Jose L. ^{[4
,5
]}

机构：

[1] Hosp Marques de Valdecilla, Div Reumatol, IDIVAL, Santander, Spain

[2] Hosp Marques de Valdecilla, Div Obstet & Gynecol, IDIVAL, Santander, Spain

[3] Hosp Marques de Valdecilla, Immunol Dept, IDIVAL, Santander, Spain

[4] Hosp Marques de Valdecilla, Div Internal Med, IDIVAL, Santander, Spain

[5] Univ Cantabria, Dept Med & Psychiat, Santander, Spain

[6] Univ Cantabria, Dept Mol Biol, Santander, Spain

来源：

AUTOIMMUNITY REVIEWS | 2024年 / 23卷 / 7-8期

关键词：

Pregnancy; Antiphospholipid syndrome; Antiphospholipid antibodies; classification; criteria; non-criteria obstetric manifestations; INTERNATIONAL CONSENSUS STATEMENT; ANTIBODIES;

D O I：

10.1016/j.autrev.2024.103592

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页数：4

共 50 条

[1] 2023 ACR/EULAR antiphospholipid syndrome classification criteria
Barbhaiya, Medha
Zuily, Stephane
Naden, Ray
Hendry, Alison
Manneville, Florian
Amigo, Mary-Carmen
Amoura, Zahir
Andrade, Danieli
Andreoli, Laura
Artim-Esen, Bahar
Atsumi, Tatsuya
Avcin, Tadej
Belmont, Michael H.
Bertolaccini, Maria Laura
Branch, D. Ware
Carvalheiras, Graziela
Casini, Alessandro
Cervera, Ricard
Cohen, Hannah
Costedoat-Chalumeau, Nathalie
Crowther, Mark
de Jesus, Guilherme
Delluc, Aurelien
Desai, Sheetal
De Sancho, Maria
Devreese, Katrien M.
Diz-Kucukkaya, Reyhan
Duarte-Garcia, Ali
Frances, Camille
Garcia, David
Gris, Jean-Christophe
Jordan, Natasha
Leaf, Rebecca K.
Kello, Nina
Knight, Jason S.
Laskin, Carl
Lee, Alfred I.
Legault, Kimberly
Levine, Steve R.
Levy, Roger A.
Limper, Maarten
Lockshin, Michael D.
Mayer-Pickel, Karoline
Musial, Jack
Meroni, Pier Luigi
Orsolini, Giovanni
Ortel, Thomas L.
Pengo, Vittorio
Petri, Michelle
Pons-Estel, Guillermo
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (10) : 1258 - 1270
[2] 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
Barbhaiya, Medha
Zuily, Stephane
Naden, Ray
Hendry, Alison
Manneville, Florian
Amigo, Mary-Carmen
Amoura, Zahir
Andrade, Danieli
Andreoli, Laura
Artim-Esen, Bahar
Atsumi, Tatsuya
Avcin, Tadej
Belmont, Michael H.
Bertolaccini, Maria Laura
Branch, D. Ware
Carvalheiras, Graziela
Casini, Alessandro
Cervera, Ricard
Cohen, Hannah
Costedoat-Chalumeau, Nathalie
Crowther, Mark
de Jesus, Guilherme
Delluc, Aurelien
Desai, Sheetal
De Sancho, Maria
Devreese, Katrien M.
Diz-Kucukkaya, Reyhan
Duarte-Garcia, Ali
Frances, Camille
Garcia, David
Gris, Jean-Christophe
Jordan, Natasha
Leaf, Rebecca K.
Kello, Nina
Knight, Jason S.
Laskin, Carl
Lee, Alfred, I
Legault, Kimberly
Levine, Steve R.
Levy, Roger A.
Limper, Maarten
Lockshin, Michael D.
Mayer-Pickel, Karoline
Musial, Jack
Meroni, Pier Luigi
Orsolini, Giovanni
Ortel, Thomas L.
Pengo, Vittorio
Petri, Michelle
Pons-Estel, Guillermo
ARTHRITIS & RHEUMATOLOGY, 2023, 75 (10) : 1687 - 1702
[3] Impact of the 2023 ACR/EULAR Classification Criteria in Women with Primary Antiphospholipid Syndrome during Pregnancy
Martinez-Taboada, Victor M.
Gomez, Ana Micieces
del Barrio-Longarela, Sara
Merino, Ana
Comins-Boo, Alejandra
Lopez-Hoyos, Marcos
Riancho-Zarrabeitia, Leyre
Galvez, Rafael
Hernandez, Jose L.
DIAGNOSTICS, 2024, 14 (19)
[4] Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
Jacobs, Lucas
Wauters, Nader
Lablad, Yahya
Morelle, Johann
Taghavi, Maxime
ANTIBODIES, 2024, 13 (01)
[5] Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria'
Tang, Zihan
Shi, Hui
Liu, Hong-Lei
Cheng, Xiaobing
Ye, Junna
Su, Yutong
Hu, Qiongyi
Meng, Jianfen
Pan, Haoyu
Yang, Chengde
Teng, Jialin
Liu, Tingting
ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (03) : e4 - e4
[6] Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry
Aiello, Anna
Sarti, Luca
Sandri, Gilda
Poli, Daniela
Sivera, Piera
Barcellona, Doris
Prisco, Domenico
Pizzini, Attilia Maria
Vercillo, Giuseppe
Antonucci, Emilia
Palareti, Gualtiero
Pengo, Vittorio
Start Antiphospholipid Registry Collaborators
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2025, 47 (02) : 313 - 317
[7] Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice
Yang, Yaqing
Jiang, Haiyue
Tang, Zihan
Pan, Haoyu
Liu, Honglei
Cheng, Xiaobing
Su, Yutong
Ye, Junna
Hu, Qiongyi
Meng, Jianfen
Chi, Huihui
Zhou, Zhuochao
Jia, Jinchao
Yang, Chengde
Shi, Hui
Teng, Jialin
Liu, Tingting
JOURNAL OF AUTOIMMUNITY, 2024, 146
[8] What about the new ACR/EULAR classification criteria for antiphospholipid syndrome?
Guettrot-Imberta, G.
Murarasua, A.
Le Guerna, V.
Chalumeau, N. Costedoat
REVUE DE MEDECINE INTERNE, 2023, 44 (11): : 581 - 584
[9] The 2023 ACR/EULAR antiphospholipid syndrome classification criteria identify patients at high risk of complications
Castillo-Martinez, Diana
Mora-Ramirez, Mauricio
Molina-Sanchez, Raul
Amezcua-Guerra, Luis M.
CLINICAL RHEUMATOLOGY, 2024, 43 (11) : 3373 - 3377
[10] Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Miro-Mur et al
Erkan, Doruk
Barbhaiya, Medha
Zuily, Stephane
Bertolaccini, Maria Laura
Willis, Rohan
Devreese, Katrien
ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (03)

← 1 2 3 4 5 →